302 related articles for article (PubMed ID: 26517758)
1. Overcoming drug resistance for macro parasites.
Srivastava M; Misra-Bhattacharya S
Future Microbiol; 2015; 10(11):1783-9. PubMed ID: 26517758
[TBL] [Abstract][Full Text] [Related]
2. A research agenda for helminth diseases of humans: intervention for control and elimination.
Prichard RK; Basáñez MG; Boatin BA; McCarthy JS; García HH; Yang GJ; Sripa B; Lustigman S
PLoS Negl Trop Dis; 2012; 6(4):e1549. PubMed ID: 22545163
[TBL] [Abstract][Full Text] [Related]
3. Foreword: towards markers for anthelmintic resistance in helminths of importance in animal and human health.
Prichard RK; von Samson-Himmelstjerna G; Blackhall WJ; Geary TG
Parasitology; 2007; 134(Pt 8):1073-6. PubMed ID: 17608966
[TBL] [Abstract][Full Text] [Related]
4. Molecular aspects of drug resistance in parasitic helminths.
Roos MH; Kwa MS; Veenstra JG; Kooyman FN; Boersema JH
Pharmacol Ther; 1993 Nov; 60(2):331-6. PubMed ID: 8022863
[TBL] [Abstract][Full Text] [Related]
5. Will technology provide solutions for drug resistance in veterinary helminths?
von Samson-Himmelstjerna G; Blackhall W
Vet Parasitol; 2005 Sep; 132(3-4):223-39. PubMed ID: 16118040
[TBL] [Abstract][Full Text] [Related]
6. Drug discovery technologies: Caenorhabditis elegans as a model for anthelmintic therapeutics.
Sepúlveda-Crespo D; Reguera RM; Rojo-Vázquez F; Balaña-Fouce R; Martínez-Valladares M
Med Res Rev; 2020 Sep; 40(5):1715-1753. PubMed ID: 32166776
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein in helminths: function and perspectives for anthelmintic treatment and reversal of resistance.
Kerboeuf D; Blackhall W; Kaminsky R; von Samson-Himmelstjerna G
Int J Antimicrob Agents; 2003 Sep; 22(3):332-46. PubMed ID: 13678840
[TBL] [Abstract][Full Text] [Related]
8. A novel high throughput assay for anthelmintic drug screening and resistance diagnosis by real-time monitoring of parasite motility.
Smout MJ; Kotze AC; McCarthy JS; Loukas A
PLoS Negl Trop Dis; 2010 Nov; 4(11):e885. PubMed ID: 21103363
[TBL] [Abstract][Full Text] [Related]
9. The drugs we have and the drugs we need against major helminth infections.
Keiser J; Utzinger J
Adv Parasitol; 2010; 73():197-230. PubMed ID: 20627144
[TBL] [Abstract][Full Text] [Related]
10. Worms--a "license to kill".
Kaminsky R; Rufener L; Bouvier J; Lizundia R; Schorderet Weber S; Sager H
Vet Parasitol; 2013 Aug; 195(3-4):286-91. PubMed ID: 23664156
[TBL] [Abstract][Full Text] [Related]
11. Anthelmintic drug discovery: into the future.
Geary TG; Sakanari JA; Caffrey CR
J Parasitol; 2015 Apr; 101(2):125-33. PubMed ID: 25584662
[TBL] [Abstract][Full Text] [Related]
12. Benzimidazole resistance in helminths: From problem to diagnosis.
Furtado LFV; de Paiva Bello ACP; Rabelo ÉML
Acta Trop; 2016 Oct; 162():95-102. PubMed ID: 27338184
[TBL] [Abstract][Full Text] [Related]
13. Anthelmintic resistance in human helminths: a review.
Geerts S; Gryseels B
Trop Med Int Health; 2001 Nov; 6(11):915-21. PubMed ID: 11703846
[TBL] [Abstract][Full Text] [Related]
14. Anthelmintic drugs and nematicides: studies in Caenorhabditis elegans.
Holden-Dye L; Walker RJ
WormBook; 2014 Dec; ():1-29. PubMed ID: 25517625
[TBL] [Abstract][Full Text] [Related]
15. Methods to sustain drug efficacy in helminth control programmes.
Albonico M
Acta Trop; 2003 May; 86(2-3):233-42. PubMed ID: 12745140
[TBL] [Abstract][Full Text] [Related]
16. Are new anthelmintics needed to eliminate human helminthiases?
Geary TG
Curr Opin Infect Dis; 2012 Dec; 25(6):709-17. PubMed ID: 23041774
[TBL] [Abstract][Full Text] [Related]
17. Using a health-rating system to evaluate the usefulness of Caenorhabditis elegans as a model for anthelmintic study.
Weaver KJ; May CJ; Ellis BL
PLoS One; 2017; 12(6):e0179376. PubMed ID: 28632749
[TBL] [Abstract][Full Text] [Related]
18. Managing anthelmintic resistance: is it feasible in New Zealand to delay the emergence of resistance to a new anthelmintic class?
Leathwick DM; Hosking BC; Bisset SA; McKay CH
N Z Vet J; 2009 Aug; 57(4):181-92. PubMed ID: 19649011
[TBL] [Abstract][Full Text] [Related]
19. Preventive Chemotherapy in the Fight against Soil-Transmitted Helminthiasis: Achievements and Limitations.
Schulz JD; Moser W; Hürlimann E; Keiser J
Trends Parasitol; 2018 Jul; 34(7):590-602. PubMed ID: 29858018
[TBL] [Abstract][Full Text] [Related]
20. Anthelmintic resistance: past, present and future.
Sangster NC
Int J Parasitol; 1999 Jan; 29(1):115-24; discussion 137-8. PubMed ID: 10048824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
